Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Harvard Business School
Novartis
Fuji
AstraZeneca
Cipla
McKinsey
Farmers Insurance
Chubb
UBS

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205973

« Back to Dashboard
NDA 205973 describes PERPHENAZINE, which is a drug marketed by Ani Pharms Inc, Vintage Pharms, Pharm Assoc, Wilshire Pharms Inc, Watson Labs Inc, Sandoz, Mylan Pharms Inc, Watson Labs, Par Pharm, Ivax Sub Teva Pharms, Mylan, and Sun Pharm Inds, and is included in forty-five NDAs. It is available from eleven suppliers. Additional details are available on the PERPHENAZINE profile page.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.

Summary for NDA: 205973

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 205973

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 205973

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERPHENAZINE
perphenazine
TABLET;ORAL 205973 ANDA Wilshire Pharmaceuticals, Inc. 52536-162 52536-162-01 100 TABLET, FILM COATED in 1 BOTTLE (52536-162-01)
PERPHENAZINE
perphenazine
TABLET;ORAL 205973 ANDA Wilshire Pharmaceuticals, Inc. 52536-164 52536-164-01 100 TABLET, FILM COATED in 1 BOTTLE (52536-164-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Dec 17, 2015TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Dec 17, 2015TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Dec 17, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Harvard Business School
Mallinckrodt
Chubb
Moodys
Express Scripts
Medtronic
Novartis
Deloitte
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot